Search results
Few Americans get recommended lung cancer screening
UPI· 5 hours agoWhile rates overall are up slightly, fewer than 1 in 5 people who are eligible for lung cancer screening are up-to-date with it, according to the...
Lung cancer screening found to prolong lives in real-world study
Medical Xpress· 17 hours agoAmong US veterans diagnosed with lung cancer through the Veterans Health Administration health care...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 5 days agoPatel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
Virtua Health offers innovative lung cancer-fighting drug
NJBIZ· 9 hours agoMarlton-headquartered Virtua Health is the first South Jersey provider to offer a groundbreaking...
Could AI & a Blood Test Help Spot Lung Cancers Early?
US News & World Report· 13 hours agoResearchers have shown that artificial intelligence (AI) can identify people who are at risk for lung cancer based on genetic markers in their blood. "We ...
This Unexpected Pain Is a Common Sign of Prostate Cancer, According to Urologists
Parade via AOL· 5 days agoMan discussing prostate cancer signs with his doctor Prostate cancer is one of the most common types...
The Unknowns Challenge Prostate Cancer Patient Partners
WebMD· 10 hours agoTreatment of lower-risk prostate cancer with surgery or radiation can take its toll on men not just because it brings the risk of death, but because it ...
Prostate screening a key part of men’s health
Gannett via AOL· 15 hours agoThat amounts to 299,010 cases, 6,150 in Maryland. Prostate cancer is also expected to be the No. 2 cause of cancer deaths among men in the U.S., behind...
Virtua Health Implements Groundbreaking Lung Cancer Technology
New Jersey Business Magazine· 4 days agoVirtua Health is the first provider in South Jersey to offer this important advancement, called...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 10 hours agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...